Department of Clinical Neuroscience
At the Department of Clinical Neuroscience (CNS), we conduct research and teaching regarding the function of the brain - from a molecular level to the effect on society.
A new study reveals first signs of human glaucoma
A new study reveals first signs of human glaucoma
Retinal ganglion cells in glaucoma patients have smaller structures and fewer mitochondria than non-diseased patients, which is an early feature of human glaucoma. This according to a new study by James Tribble published in the journal Brain Communications.
People with cluster headache have twice as many sick-leave days as those without
People with cluster headache have twice as many sick-leave days as those without
In a new Swedish study, published in the medical journal Neurology, it was found that people with cluster headache have twice as many sick-leave days as people without. The researchers also found that women with cluster headache had twice as many sick-leave days as men with the same disease. That an episodic disease has some effect on working life was expected, but not that the differences were that large.
Lecture on Climate Change with Alasdair Skelton from the Department Day 2019
New review article on suicide published
New review article on suicide published
Bo Runeson and his colleague Seena Fazel from University of Oxford has written a review article about the current state of research on suicide prevention. The article was published in New England Journal of Medicine.
Age-related macular degeneration research receives SEK 1.4 million grant from ARMEC Lindebergs Stiftelse
Age-related macular degeneration research receives SEK 1.4 million grant from ARMEC Lindebergs Stiftelse
Helder André, researcher at St. Erik Eye Hospital and Karolinska Institutet, is granted SEK 1.4 million from ARMEC Lindebergs Stiftelse for his research project ”Novel Gene Therapy Strategies for the Sustainable Treatment of Age-related Macular Degeneration”
Long-term medication for schizophrenia is safe
Long-term medication for schizophrenia is safe
Researchers at CNS and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia. According to the study, which is published in the scientific journal World Psychiatry, mortality was higher during periods when patients were not on medication than when they were.
KI researchers listed among historical celebrities
KI researchers listed among historical celebrities
Tomas Olsson at CNS is one of the about 20 researchers at KI that can brag about being included in the highly cited researchers list from Google Scholar, together with historical super-celebrities such as Einstien and Freud.
Environment and Sustainable Development at CNS
We as part of a University has a central roll in the work to combat climate change, both by contributing through teaching and research, but we also need to contribute by reducing the impact of our own activities. Here you can find tips on what changes you can do in your daily life to reduce your climate footprint.
GDPR at KI
The General Data Protection Regulation (GDPR, or Dataskyddsförordningen) for the processing of personal data is to be applied on May 25 2018 in Sweden. Here you will find information on GDPR and the implementation of the regulation at KI.